What is a common pharmacologic approach to treat opioid-induced pruritus if needed?

What is a common pharmacologic approach to treat opioid-induced pruritus if needed?

• A. Antihistamines or partial agonist/antagonist opioids.
• B. Increasing the opioid dose.
• C. Vitamin K administration.
• D. Corticosteroids only.

Answer: (A)

Opioid-induced pruritus is often histamine-mediated when certain opioids activate mast cells, causing itch. A common pharmacologic way to treat this if needed is to give an antihistamine to block the histamine effect, typically an H1 blocker like diphenhydramine, which can reduce the sensation of itching and often helps with the associated sedation. If itch persists, one can use a partial agonist/antagonist opioid such as nalbuphine or butorphanol. These agents activate κ receptors while blocking μ receptors, decreasing μ-mediated itch and often still providing analgesia, which can relieve the pruritus without increasing histamine release. Other options listed, such as increasing the opioid dose, are likely to worsen itching, and vitamin K or corticosteroids alone are not standard treatments for this acute, opioid-related itch.

Opioid-induced pruritus is often histamine-mediated when certain opioids activate mast cells, causing itch. A common pharmacologic way to treat this if needed is to give an antihistamine to block the histamine effect, typically an H1 blocker like diphenhydramine, which can reduce the sensation of itching and often helps with the associated sedation.

If itch persists, one can use a partial agonist/antagonist opioid such as nalbuphine or butorphanol. These agents activate κ receptors while blocking μ receptors, decreasing μ-mediated itch and often still providing analgesia, which can relieve the pruritus without increasing histamine release.

Other options listed, such as increasing the opioid dose, are likely to worsen itching, and vitamin K or corticosteroids alone are not standard treatments for this acute, opioid-related itch.